Vincent A
J Recept Res. 1987;7(1-4):599-616. doi: 10.3109/10799898709055004.
Myasthenia gravis (MG) is an autoimmune disease in which anti-acetylcholine receptor antibodies (anti-AChR) cause loss of functional endplate AChR by increasing AChR degradation, and by complement-mediated destruction. MG anti-AChR binds to regions on the human AChR which can be defined by monoclonal antibodies (mabs). Several congenital forms of myasthenia have been described, three of which may directly involve abnormalities of the AChR, including one in which the open-time of the ion channel is prolonged.
重症肌无力(MG)是一种自身免疫性疾病,其中抗乙酰胆碱受体抗体(抗AChR)通过增加AChR降解以及补体介导的破坏,导致功能性终板AChR丧失。MG抗AChR与人类AChR上可由单克隆抗体(mabs)界定的区域结合。已描述了几种先天性重症肌无力形式,其中三种可能直接涉及AChR异常,包括一种离子通道开放时间延长的情况。